New Partnership Between Sheba and Sight Diagnostics Supports COVID-19 Quarantine Measures
A compact blood analyzer developed by an Israeli blood testing startup has been implemented to support the healthcare management of coronavirus-infected patients.
Sheba Medical Center recently established a new collaboration with Sight Diagnostics. This Israeli startup created the OLO blood analyzer, which provides rapid CBC (complete blood count) results using a method that minimizes the risk of contamination for medical staff. The blood results are processed in a specialized laboratory set up to help monitor coronavirus COVID-19 patients who are hospitalized in an isolation facility.